The Royal Liverpool University Hospital is a major teaching and research hospital located in the city of Liverpool, England. It is the largest and busiest hospital in Merseyside and Cheshire, and has the largest emergency department of its kind in the UK.

There are 850 beds in Royal Liverpool University Hospital.

During the past decade, Royal Liverpool University Hospital conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 47 clinical trials were completed, i.e. on average, 44.8% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 34 clinical trials were completed. i.e. 91.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Liverpool University Hospital" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "University of Liverpool" with 10 trials sponsored, "Gilead Sciences" with 8 trials sponsored, "Liverpool University Hospitals NHS Foundation Trust" with 8 trials sponsored and "Celgene" with 8 trials sponsored. Other sponsors include 176 different institutions and companies that sponsored additional 122 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Liverpool University Hospital" #1 collaborator was "Cancer Research UK" with 18 trials as a collaborator, "Liverpool University Hospitals NHS Foundation Trust" with 11 trials as a collaborator, "University of Liverpool" with 6 trials as a collaborator, "Medical Research Council" with 5 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator. Other collaborators include 178 different institutions and companies that were collaborators in the rest 147 trials.

According to Clinical.Site data, the most researched conditions in "Royal Liverpool University Hospital" are "Breast Cancer" (12 trials), "Lymphoma" (7 trials), "Multiple Myeloma" (7 trials), "Colorectal Cancer" (6 trials) and "Myelodysplastic Syndrome" (6 trials). Many other conditions were trialed in "Royal Liverpool University Hospital" in a lesser frequency.

Most popular intervention types in "Royal Liverpool University Hospital" are "Drug" (164 trials), "Other" (39 trials), "Procedure" (29 trials), "Biological" (24 trials) and "Device" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "cyclophosphamide" (11 trials), "Rituximab" (10 trials), "doxorubicin hydrochloride" (8 trials) and "vincristine sulfate" (7 trials). Other intervention names were less common.

The vast majority of trials in "Royal Liverpool University Hospital" are 207 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Liverpool University Hospital". 1 are not yet recruiting, 25 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in Royal Liverpool University Hospital, 1 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Liverpool University Hospital, 21 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 25 trials that are defined as “Not Applicable".

Royal Liverpool University Hospital has several departments that took part in Clinical trials: "Royal Liverpool University Hospital; St Paul's Clinical Eye Research Centre" - 7 trials, "Royal Liverpool Uni Hospital; Haematology" - 3 trials, "Roald Dahl Haemostasis and Thrombosis Centre, Royal Liverpool University Hospital, Liverpool University Hospitals NHS Foundation Trust" - 2 trials, "Intensive Care Unit, Royal Liverpool University Hospital" - 2 trials, "Royal Liverpool Childrens Hospital; Rheumatology" - 2 trials